[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334268-105":59,"doc-detail-334268-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","gg-ners-role-in-androgen-receptor-signaling-inhibitor-response-for-advanced-prostate-cancer","GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer","","Advanced prostate cancer often shows initial sensitivity to androgen receptor signaling inhibitors (ARSI) but commonly develops resistance under tumor heterogeneity and therapeutic pressure. This study uses single-sample gene set enrichment analysis to quantify how the GG-NER pathway influences ARSI response, then builds a prognostic model with LASSO, Kaplan-Meier, Cox, and ROC methods. Tumor mutations and pathways are assessed with GO, KEGG, and GSEA, with functional validation via CCK-8, colony formation, in vivo studies, and immunofluorescence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/gg-ners-role-in-androgen-receptor-signaling-inhibitor-response-for-advanced-prostate-cancer/334268/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/gg-ners-role-in-androgen-receptor-signaling-inhibitor-response-for-advanced-prostate-cancer/334268.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does advanced prostate cancer often develop resistance to androgen receptor signaling inhibitors?","Question",{"text":112,"@type":113},"Resistance arises despite initial ARSI sensitivity, driven by tumor heterogeneity and the selective pressure of therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the GG-NER pathway linked to ARSI response in this study?",{"text":117,"@type":113},"Single-sample gene set enrichment analysis (ssGSEA) was used to evaluate the GG-NER pathway’s influence on ARSI response, followed by a prognostic model built with LASSO regression, Kaplan-Meier, Cox regression, and ROC analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports targeting the GG-NER pathway to reduce enzalutamide resistance?",{"text":121,"@type":113},"Functional assays (CCK-8 and colony formation), in vivo experiments, and immunofluorescence showed that targeting the GG-NER pathway or its key gene ACTL6A reduces enzalutamide resistance and increases γH2AX expression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334268,1790197795,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Zhong et al. Cell Communication and Signaling (2024) 22:600  \n[https://doi.org/10.1186/s12964-024-01977-0](https://doi.org/10.1186/s12964-024-01977-0)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nGG-NER’s role in androgen receptor signaling  inhibitor response for advanced prostate  \ncancer  \nChuanfan Zhong 1,2†, Jiaxing Wang 1†, Hangyang Peng 1†, Jianming Lu3*, Zining Long 1, Zhuoyuan Lin4, Guo Chen5, Chao Cai6, Shilong Cheng 1, Zhongjie Chen 1, Le Zhang7, Weibo Zhong 1*, Rujun Mo2* and Xiangming Mao 1*  \nAbstract  \nBackground Advanced prostate cancer (PCa) often initially responds to androgen receptor signaling inhibitors (ARSI) but frequently develops resistance, driven by tumor heterogeneity and therapeutic pressure. Addressing the clinical challenge of identifying non-responsive patients and discovering new therapeutic targets is urgently needed. Methods We utilized single-sample gene set enrichment analysis (ssGSEA) to elucidate the influence of the GG-NER pathway on ARSI response in PCa. We then constructed and validated a prognostic model based on this pathway using LASSO regression, Kaplan-Meier analysis, Cox regression, and ROC analysis. Additionally, we mapped tumor mutations to delineate the mutational landscapes across different risk groups and explored functional pathways through GO, KEGG, and GSEA analyses. The impact of the GG-NER pathway on enzal utamide sensitivity and  \nDNA repair in PCa was further validated through CCK-8 assays, colony formation assays, in vivo experiments, and immunofluorescence.  \nResults ssGSEA indicated a trend of GG-NER pathway upregulation in patients with poor ARSI response. The  \nGG-NER characteristic gene score (NECGS) identified a high-risk group with diminished ARSI response, serving asan independent prognostic indicator with strong predictive power. This high-risk group exhibited elevated TP53 mutation frequencies and significant enrichment in key pathways such as ribosome and mitochondrial functions, as well as MYC and E2F signaling. Experimental validation confirmed that targeting the GG-NER pathway or its key gene, ACTL6A, significantly reduces enzal utamide resistance in resistant cell lines and increases γH2AX expression.  \n†Chuanfan Zhong, Jiaxing Wang and Hangyang Peng contributed equally to this work.  \n*Correspondence: Jianming Lu [louiscfc8@gmail.com](louiscfc8@gmail.com)[ ](louiscfc8@gmail.com)Weibo Zhong [zwbo19920709@163.com](zwbo19920709@163.com)[ ](zwbo19920709@163.com)Rujun Mo[rmo@smu.edu.cn](rmo@smu.edu.cn)[ ](rmo@smu.edu.cn)Xiangming Mao [mxm@smu.edu.cn](mxm@smu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nZhong et al. Cell Communication and Signaling (2024) 22:600 Page 2 of 17  \nConclusion NECGS effectively predicts ARSI response in PCa, and our comprehensive analysis underscores the critical role of the GG-NER pathway in enzal utamide resistanc","cbCaijXBaGnQxC1n","https://ap.wps.com/l/cbCaijXBaGnQxC1n","pdf",11801517,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Treatment landscape and resistance\n## DNA damage repair and therapeutic rationale","[{\"question\":\"Why does advanced prostate cancer often develop resistance to androgen receptor signaling inhibitors?\",\"answer\":\"Resistance arises despite initial ARSI sensitivity, driven by tumor heterogeneity and the selective pressure of therapy.\"},{\"question\":\"How was the GG-NER pathway linked to ARSI response in this study?\",\"answer\":\"Single-sample gene set enrichment analysis (ssGSEA) was used to evaluate the GG-NER pathway’s influence on ARSI response, followed by a prognostic model built with LASSO regression, Kaplan-Meier, Cox regression, and ROC analysis.\"},{\"question\":\"What experimental evidence supports targeting the GG-NER pathway to reduce enzalutamide resistance?\",\"answer\":\"Functional assays (CCK-8 and colony formation), in vivo experiments, and immunofluorescence showed that targeting the GG-NER pathway or its key gene ACTL6A reduces enzalutamide resistance and increases γH2AX expression.\"}]","GG-NER’s role in androgen receptor signaling inhibitor response for advanced prostate cancer | PDF",1790006080,43]